Article
Intravitreal triamcinolone may be beneficial option for DME
New Brunswick, NJ-Results of a retrospective study suggest that intravitreal triamcinolone acetonide may be a beneficial treatment for eyes with diabetic macular edema (DME), said Janet J. Chieh, MD.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Content
